Withholding thrombolysis in patients with diabetes mellitus and acute myocardial infarction

Diabetic Medicine

Volumn 15, Issue 12, 1998, Pages 1028-1030

  Shotliff, K ^a   Kaushal, R ^a   Dove, D ^b   Nussey, S S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Clinical practice; Diabetes mellitus; Myocardial infarction; Thrombolysis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; MALE; RETINOGRAPHY; TREATMENT PLANNING;

DIABETES MELLITUS, TYPE 1; EMERGENCY SERVICE, HOSPITAL; ENGLAND; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HOSPITALS, TEACHING; HUMANS; INTERVIEWS; LONDON; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; MYOCARDIAL INFARCTION; QUESTIONNAIRES; THROMBOLYTIC THERAPY;

EID: 0031737339     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(1998120)15:12<1028::AID-DIA713>3.0.CO;2-S     Document Type: Article

References (13)

1. Czyzk A, Krolewski AS, Alot A, et al. Clinical course of myocardial infarction among diabetic patients. Diabetes Care 1980; 3: 526-529.
2. Woods KL, Samanta A, Burden AC. Diabetes mellitus as a risk factor for acute myocardial infarction in Asians and Europeans. Br Heart J 1989; 62: 118-122.
3. Fuller J, Shipley M, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of hyperglycaemia. The Whitehall study. Br Med J 1983; 287: 867-870.
4. Granger CB, Califf RM, Young S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 1993; 21: 920-925.
5. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992; 20: 736-744.
6. Ward H, Yudkin JS. Thrombolysis in patients with diabetes. Br Med J 1995; 310: 1-4.
7. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, vol. 35. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1998: 114.
8. Yudkin JS. Managing the diabetic patient with acute myocardial infarction. Diabetic Med 1998; 15: 276-281.
9. Higgs ER, Parfitt VJ, Harney BA, Hartog M. Use of thrombolysis for acute myocardial infarction in the presence of diabetic retinopathy in the UK, and associated ocular haemorrhagic complications. Diabetic Med 1995; 12: 426-428.
10. Hood S, Birnie D, Curzio JL and Hills WS. Wide variation in the use of thrombolytic therapy amongst junior doctors in south and central Scotland. Health Bulletin 1996; 54: 131-139.
11. Fibrinolytic Therapy Trialist's (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 100 patients. Lancet 1994; 343: 311-322.
12. Grekos ZG, Schocken DD. Bilateral vitreous haemorrhage as a consequence of thrombolytic therapy successfully treated with vitrectomy in patient without diabetes. Am Heart J 1995; 130: 611-612.
13. Fava S, Azzopardi J, Muscat HA, Fenech FK. Risk of intraocular haemorrhage remains unknown. Br Med J 1995; 310: 1009.